Insider Trading April 10, 2026 09:13 PM

Aehr Test Systems CTO Disposes $1.08 Million in Stock as Company Posts Mixed Q3 Results

Donald Richmond II sold 15,751 shares on April 9, 2026; company reported bookings strength but missed revenue expectations for fiscal Q3 2026

By Nina Shah AEHR
Aehr Test Systems CTO Disposes $1.08 Million in Stock as Company Posts Mixed Q3 Results
AEHR

Aehr Test Systems Chief Technology Officer Donald P. Richmond II executed a sale of 15,751 shares on April 9, 2026, generating roughly $1.08 million. The transaction occurred while the share price is trading near a 52-week high amid a year-over-year surge. Separately, the company released mixed fiscal third-quarter results that included stronger-than-expected bookings but a revenue shortfall versus forecasts.

Key Points

  • Aehr Test Systems CTO Donald P. Richmond II sold 15,751 shares on April 9, 2026, for $68.6849 per share, totaling $1,081,855.
  • After the sale Richmond directly owns 199,245 shares, which include unvested restricted stock units.
  • The company posted mixed fiscal Q3 2026 results - EPS of -$0.05 beat the -$0.07 forecast, but revenue of $10.3 million missed the $10.8 million expectation; bookings were strong at $37.2 million with a book-to-bill above 3.5x.

Transaction details

Donald P. Richmond II, Chief Technology Officer of Aehr Test Systems (NASDAQ: AEHR), sold 15,751 shares of the company's common stock on April 9, 2026, according to a Form 4 filing with the Securities and Exchange Commission. The shares were disposed at a per-share price of $68.6849, producing a total transaction value of $1,081,855. The filing bears the signature of Chris Siu, Attorney-in-Fact, dated April 10, 2026.

Post-sale ownership

Following this disposition, Richmond directly holds 199,245 shares of Aehr Test Systems common stock. That reported holding includes unvested restricted stock units.

Share price context

At the time of reporting, Aehr Test Systems shares were trading at $70.43, close to a 52-week high of $72.50. The share price is noted to have climbed roughly 727% over the last 12 months. Independent analysis referenced in the filing indicates InvestingPro considers the shares overvalued at current levels. The company also has an available Pro Research Report on InvestingPro for subscribers seeking additional details.

Recent financial results

In other corporate disclosures, Aehr Test Systems released its fiscal third-quarter results for 2026. The company reported a loss per share of $0.05, which was better than the consensus forecast loss of $0.07. Revenue for the quarter came in at $10.3 million, falling short of the expected $10.8 million. Despite the revenue shortfall, bookings were reported at $37.2 million for the quarter and the company achieved a book-to-bill ratio in excess of 3.5x.

Analyst reaction

Following the quarterly update and the disclosed bookings strength, Lake Street adjusted its price target on Aehr Test Systems to $56 from $50 and maintained a Buy rating, citing the robust bookings momentum as a positive factor for the company’s future outlook.

What the disclosure shows

The insider sale, the company’s mixed quarterly performance and the analyst action provide a snapshot of Aehr Test Systems’ current public profile: management continues to hold substantial equity after the sale, the company is reporting operational booking strength even as near-term revenue missed expectations, and market commentary flags valuation concerns.


Note: The information above is drawn from the company filing, the company's reported fiscal results, and cited analyst commentary as stated in the disclosures.

Risks

  • Valuation concern - InvestingPro analysis cited in disclosures indicates the stock appears overvalued at current price levels, posing a market risk for equity investors.
  • Revenue shortfall - Quarterly revenue of $10.3 million missed the $10.8 million consensus, highlighting near-term top-line execution risk.
  • Insider selling - The CTO’s sale may be perceived by some investors as a negative signal, potentially affecting sentiment in the equity and capital markets.

More from Insider Trading

CoreWeave CSO Venturo Disposes $5.51 Million in Class A Shares Under 10b5-1 Plan Apr 10, 2026 CoreWeave COO Sells Shares as Company Signs Major AI and Cloud Deals, Prices Convertible Notes Apr 10, 2026 CoreWeave Executive Sells Nearly $900,000 in Class A Stock as Company Announces Major Contract and Financing Moves Apr 10, 2026 CoreWeave CEO Sells $5.57 Million in Class A Shares as Company Advances Major AI and Cloud Deals Apr 10, 2026 CoreWeave CFO Executes Small Sale as Company Secures Major Contract and Debt Financing Apr 10, 2026